ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : University/Organization : Johns Hopkins Oncology Center

Include trials that are no longer recruiting patients.

13 studies were found.
1.No longer recruitingBone Marrow Transplantation Plus Biological Therapy in Treating Patients With Chronic Myeloid Leukemia
Conditions: Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; ...
2.CompletedCombination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer
Conditions: ovarian serous cystadenocarcinoma; ovarian clear cell cystadenocarcinoma; recurrent ovarian epithelial cancer; ovarian endometrioid adenocarcinoma; ...
3.No longer recruitingDonor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
Conditions: untreated adult acute myeloid leukemia; chronic phase chronic myelogenous leukemia; Previously Treated Myelodysplastic Syndrome; ...
4.No longer recruitingGadolinium Texaphyrin Plus Radiation Therapy in Treating Patients With Supratentorial Glioblastoma Multiforme
Condition: adult glioblastoma multiforme
5.No longer recruitingInterferon alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
Conditions: Philadelphia chromosome positive chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; ...
6.CompletedIrinotecan in Treating Patients With Recurrent Malignant Glioma
Conditions: adult glioblastoma multiforme; adult anaplastic astrocytoma; recurrent adult brain tumor
7.No longer recruitingO6-benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma
Conditions: Adult Oligodendroglioma; recurrent adult brain tumor; adult glioblastoma multiforme; adult ependymoma; adult anaplastic astrocytoma; ...
8.No longer recruitingPeripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors
Conditions: childhood liver cancer; Bone Cancer; Testicular Cancer; Brain Tumor
9.No longer recruitingPhase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus
Condition: Pemphigus
10.No longer recruitingPhase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease
Conditions: Anemia, Hemolytic, Autoimmune; Felty Syndrome; Purpura, Thrombocytopenic; Autoimmune Diseases
11.CompletedPilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody Syndrome
Conditions: Systemic Lupus Erythematosus; Antiphospholipid Antibody Syndrome
12.RecruitingStudy of High Dose Cyclophosphamide in Patients with Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria
Conditions: Aplastic Anemia; Paroxysmal Hemoglobinuria, Nocturnal
13.No longer recruitingTotal-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers
Conditions: Leukemia; Lymphoma; Multiple Myeloma

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act